ByTrending Posts
How Did AbbVie’s 2025 Deals Shape Its Year,…
NORTH CHICAGO, IL — As 2025 concludes, AbbVie Inc. reflects on a year of strategic dealmaking that complements…
Did AbbVie Successfully Manage 2025 Headwinds, and Are…
NORTH CHICAGO, ILLINOIS — As 2025 comes to a close, AbbVie reflects on a year marked by strong…
Is Lilly Shaping Its Post-Blockbuster Future Through Verve,…
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster brands driving growth…
Is Lilly Strengthening Its 2026 Growth Outlook by…
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a focused strategy centered…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping…
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at strengthening its pipeline,…
Can Pfizer’s 2025 Execution Set the Stage for…
NEW YORK, NY — As 2025 comes to a close, Pfizer Inc. reflects on a year marked by…
Will the US Health Agency Expand Coverage for…
The U.S. Centers for Medicare & Medicaid Services (CMS) announced a new voluntary program to expand coverage of…
How is Bristol Myers Squibb Driving Growth After…
Bristol Myers Squibb (BMS) continues to build momentum in its post-loss-of-exclusivity strategy, with 2025 marked as a year…
Will Agios Pharma’s FDA Approval Expansion Drive a…
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the U.S. Food and…
Trending Posts
Latest Stories
Merck Reinforces Oncology Leadership and Therapeutic Area Depth with Robust 2025 Performance
Rahway, NJ – February 2026 – Merck & Co., Inc. reported strong full-year 2025 financial…
AbbVie Accelerates Portfolio-Led Growth in 2025 and Strengthens Its Long-Term Therapeutic Leadership
North Chicago, IL – February 2026 – AbbVie Inc. reported a strong full-year financial performance…
Did Abivax Just Quash Acquisition Rumors by Eli Lilly — and What It Means for Its IBD Breakthrough Asset?
January 26, 2026 — Paris & Global — Abivax SA, the French clinical‑stage biotechnology company, this week…
Could Sun Pharma’s Bold Bid for Organon Redefine Its U.S. Strategy and Global Footprint?
January 25, 2026 — Mumbai & New York — Sun Pharmaceutical Industries Ltd. (Sun Pharma), India’s largest…
Gallery
